Cruiser Capital Advisors, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Cruiser Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.89 - $7.91 $106,606 - $291,784	-36,888 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.59 - $10.45 $22,360 - $41,800	4,000 Added 12.16%	36,888 $301,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $50,968 - $79,134	-6,387 Reduced 16.26%	32,888 $320,000
Q4 2017 Feb 14, 2018	BUY	$8.69 - $14.59 $341,299 - $573,022	39,275	39,275 $492,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Cruiser Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cruiser Capital Advisors, LLC with notifications on news.